E-LIB Suche - Ergebnisse für: Casasnovas, René-Olivier

1

Oral azacitidine compared with standard therapy in patients..:

Dupuis, Jehan ; Bachy, Emmanuel ; Morschhauser, Franck...
The Lancet Haematology. 11 (2024) 6 - p. e406-e414 , 2024

Link: https://doi.org/10.1016/..

2

Treatment Strategies in Advanced-Stage Hodgkin Lymphoma:

Dann, Eldad J. ; Casasnovas, René-Olivier
Cancers. 16 (2024) 11 - p. 2059 , 2024

Link: https://doi.org/10.3390/..

3

IELSG38: phase II trial of front-line chlorambucil plus sub..:

Stathis, Anastasios ; Pirosa, Maria Cristina ; Orsucci, Lorella...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

4

Nonrelapse mortality after CAR T-cell therapy for large B-c..:

Lemoine, Jean ; Bachy, Emmanuel ; Cartron, Guillaume...
Blood Advances. 7 (2023) 21 - p. 6589-6598 , 2023

Link: https://doi.org/10.1182/..

5

Graph-Based Multimodal Multi-lesion DLBCL Treatment Respons..:

, In: Medical Image Computing and Computer Assisted Intervention – MICCAI 2023 Workshops; Lecture Notes in Computer Science,

Thiery, Oriane ; Rizkallah, Mira ; Bailly, Clément... - p. 103-112 , 2023

Link: https://doi.org/10.1007/..

6

HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety i..:

Carlo-Stella, Carmelo ; Ansell, Stephen ; Zinzani, Pier Luigi...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S347 , 2022

Link: https://doi.org/10.1016/..

7

A real-world comparison of tisagenlecleucel and axicabtagen..:

Bachy, Emmanuel ; Le Gouill, Steven ; Di Blasi, Roberta...
Nature Medicine. 28 (2022) 10 - p. 2145-2154 , 2022

Link: https://doi.org/10.1038/..

8

Poster: HL-339 Camidanlumab Tesirine: Updated Efficacy and ..:

Carlo-Stella, Carmelo ; Ansell, Stephen ; Zinzani, Pier Luigi...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S162 , 2022

Link: https://doi.org/10.1016/..

9

The Association between Patient Characteristics and the Eff..:

Zijlstra, Josée M. ; Follows, George ; Casasnovas, Rene-Olivier...
Cancers. 14 (2022) 3 - p. 791 , 2022

Link: https://doi.org/10.3390/..

10

Comparison of the Effectiveness and Safety of the Oral Sele..:

Casasnovas, Rene-Olivier ; Follows, George ; Zijlstra, Josee M....
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 1 - p. 24-33 , 2022

Link: https://doi.org/10.1016/..

11

PD-1 inhibitors in patients with Hodgkin lymphoma:

Rossi, Cédric ; Casasnovas, René-Olivier
European Journal of Cancer. 164 (2022) - p. 114-116 , 2022

Link: https://doi.org/10.1016/..

12

Effect of Prior Therapy and Disease Refractoriness on the E..:

Schuster, Michael ; Zijlstra, Josée ; Casasnovas, Rene-Olivier...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 7 - p. 483-494 , 2022

Link: https://doi.org/10.1016/..

13

Bendamustine-EAM versus R-BEAM after high-dose cytarabine-b..:

Costes-Tertrais, Domitille ; Hueso, Thomas ; Gastinne, Thomas...
Bone Marrow Transplantation. 57 (2022) 4 - p. 627-632 , 2022

Link: https://doi.org/10.1038/..

14

Oral Abstract: HL-339 Camidanlumab Tesirine: Updated Effica..:

Carlo-Stella, Carmelo ; Ansell, Stephen ; Zinzani, Pier Luigi...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S118 , 2022

Link: https://doi.org/10.1016/..

15

Influence of Sociodemographic Determinants on the Hodgkin L..:

Chevreux, Steeve ; de Barros, Sandra ; Laurent, Camille...
Cancers. 15 (2022) 1 - p. 53 , 2022

Link: https://doi.org/10.3390/..